Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Gumin

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Neurology|April 21, 2023
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profilesLea M Stitzlein, Achintyan Gangadharan, Leslie M Walsh, et al.
Oncogene|April 22, 2014
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastomaXia Li, Yuexin Liu, Kirsi J Granberg, et al.
Journal of Neurosurgery|January 13, 2018
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastomaMarkus M Luedi, Sanjay K Singh, Jennifer C Mosley, et al.
Oncotarget|April 18, 2018
A gene expression signature predicts recurrence-free survival in meningiomaAdriana Olar, Lindsey D Goodman, Khalida M Wani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant GliomasAlessandro Canella, Alessandra M Welker, Ji Young Yoo, et al.
Neuro-Oncology|April 7, 2019
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesisAnantha L Marisetty, Li Lu, Bethany L Veo, et al.
Scientific Reports|August 16, 2018
REST overexpression in mice causes deficits in spontaneous locomotionLi Lu, Anantha Marisetty, Bin Liu, et al.
Neuro-Oncology Advances|January 7, 2026
Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastomaLea M Stitzlein, Deokhwa Nam, Faith A Hernandez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2024
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized miceDong Ho Shin, Hong Jiang, Andrew G Gillard, et al.
Science Advances|August 4, 2023
Multiomics analyses reveal <i>DARS1-AS1</i>/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistanceCaishang Zheng, Yanjun Wei, Qiang Zhang, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Neurology|April 21, 2023
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profilesLea M Stitzlein, Achintyan Gangadharan, Leslie M Walsh, et al.
Oncogene|April 22, 2014
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastomaXia Li, Yuexin Liu, Kirsi J Granberg, et al.
Journal of Neurosurgery|January 13, 2018
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastomaMarkus M Luedi, Sanjay K Singh, Jennifer C Mosley, et al.
Oncotarget|April 18, 2018
A gene expression signature predicts recurrence-free survival in meningiomaAdriana Olar, Lindsey D Goodman, Khalida M Wani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant GliomasAlessandro Canella, Alessandra M Welker, Ji Young Yoo, et al.
Neuro-Oncology|April 7, 2019
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesisAnantha L Marisetty, Li Lu, Bethany L Veo, et al.
Scientific Reports|August 16, 2018
REST overexpression in mice causes deficits in spontaneous locomotionLi Lu, Anantha Marisetty, Bin Liu, et al.
Neuro-Oncology Advances|January 7, 2026
Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastomaLea M Stitzlein, Deokhwa Nam, Faith A Hernandez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2024
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized miceDong Ho Shin, Hong Jiang, Andrew G Gillard, et al.
Science Advances|August 4, 2023
Multiomics analyses reveal <i>DARS1-AS1</i>/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistanceCaishang Zheng, Yanjun Wei, Qiang Zhang, et al.
Pageof 7